SimonMed Launches World’s First Enterprise-Scale Integrated AI Lung Nodule Risk Assessment Workflow
Multiple FDA-cleared AI technologies are integrated into a single clinical workflow for lung nodule detection, characterization and malignancy-risk prediction—without disrupting…